Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-07
2011-06-07
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S114000
Reexamination Certificate
active
07956068
ABSTRACT:
The present invention relates to compounds of formula (I)wherein c, X, Y, R2, R3, R4and R6are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
REFERENCES:
patent: 2600832 (2006-10-01), None
patent: 2606282 (2006-11-01), None
patent: 2622639 (2007-04-01), None
patent: 2626956 (2007-05-01), None
International Search Report, Form PCT/ISA/210, for corresponding PCT/CA2008/001935; date of mailing: Jan. 26, 2009.
Brochu Christian
Carson Rebekah J.
Fader Lee
Kawai Stephen
Landry Serge R.
Boehringer Ingelheim International GmbH
Habte Kahsay T
Morris Michael P.
Stempel Alan R.
LandOfFree
Inhibitors of human immunodeficiency virus replication does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of human immunodeficiency virus replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of human immunodeficiency virus replication will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660575